Sees FY26 center Margin $526M-$550M, and Adjusted EBITDA of $185M-$205M.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFST:
- LifeStance: Improving Utilization, Stronger Fundamentals, and Tech-Driven Growth Support Buy Rating
- Lifestance Health Group, Inc. (LFST) Q4 Earnings Cheat Sheet
- LifeStance price target raised to $11 from $10 at BTIG
- LifeStance Health Group: Operational Efficiency Initiatives Undervalued, Supporting Buy Rating and Upside Potential
- LifeStance price target raised to $8.50 from $6.50 at KeyBanc